Events, Presentations and Media
Financial Calender
Report/event | Expected date |
Year end Report 2023 | February 29, 2024 |
Annual Report 2023 | May 10, 2024 |
Interim report, January – March (Q1) | May 31, 2024 |
Annual General Meeting | June 14, 2024 |
Interim Report April – June (Q2) | August 30, 2024 |
Interim Report July- September (Q3) | November 29, 2024 |
Year end Report 2024 | March 31, 2025 |
Company presentation
Media
Interview with Tine Kold Olesen, CEO link
Biosergen and Invasive Fungal Infections link
1 pager investor link
Biosergen and Invasive fungal infections link
2021.05.27 Biostock link
Biostock interview June 1, 2021 Video link
Interview with Peder M Andersen Video link